Medical Care Technologies Inc. (OTC PINK:MDCE) Marches Forward with Breakthrough Patent-Pending AI Healthcare Solutions using Smart Devices

A very unique multi-vertical health AI engine capable of early detection for mental health, wound infection, skin cancer, and disease risk-all through a smartphone

MESA, ARIZONA / ACCESS Newswire / November 10, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a major technological milestone with the development of its patent-pending AI health platform (U.S. Provisional Patent Application No. 63/854,935), engineered to bring real-time diagnostic intelligence directly to smartphones. This system represents a breakthrough in mobile health screening by enabling early detection of high-risk medical conditions-without requiring specialized hardware, clinical visits, or expensive imaging devices.

Foto: Accesswire

Built on advanced deep learning, temporal image analysis, and affective computing, MDCE's platform is designed to identify early health indicators with precision previously limited to clinical environments. The Company is actively developing four core AI verticals-mental health screening, wound monitoring, skin cancer detection, and predictive health risk analysis-targeting rapidly growing markets valued collectively in the trillions.

"Our mission is to make proactive health screening not only accessible, but effortless," said Marshall Perkins, CEO of Medical Care Technologies Inc. "If we can give people the ability to detect risk earlier-whether it's melanoma, infection, or silent mental health decline-then we unlock a new era of preventative, data-driven healthcare. This is not the future of diagnostics; it is the beginning of a new standard of care delivered through everyday technology."

A Scalable AI Ecosystem Targeting Critical Healthcare Gaps

MDCE's multi-vertical platform aims to transform how patients approach preventative care:

• AI Mental Health Screening
  Uses high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to identify early signs of anxiety, depression, and PTSD-supporting a digital mental health market already exceeding $400 billion globally.

• AI Wound Monitoring
  Analyzes sequential imaging for infection risk, tissue deterioration, and healing progression-impacting the global chronic wound care market projected to surpass $30 billion by 2030.

• AI Skin Cancer Screening
  Employs full-body lesion mapping, 3D indexing, and temporal skin-change detection to enable population-scale early melanoma awareness within a $15+ billion dermatology diagnostics market.